Mitsubishi Tanabe Pharma
Major Japanese pharmaceutical company with a rich history, focused on developing innovative therapies for central nervous system disorders, autoimmune diseases, and other serious conditions.
Location
Osaka, Japan
Founded
1678
Categories
pharma, therapeutics, als, autoimmune, central-nervous-system
Notes
Mitsubishi Tanabe Pharma is one of Japan's oldest and largest pharmaceutical companies, with origins dating back to 1678. The company is a subsidiary of Mitsubishi Chemical Holdings Corporation and focuses on developing innovative medicines in areas including central nervous system disorders, autoimmune diseases, and diabetes.
The company is known for developing Radicava (edaravone), an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), and has a diverse pipeline of therapeutics in various stages of development.
Team
- Hiroaki Ueno - Representative Director, President & CEO
Additional Research Findings
- Founded in 1678 (one of oldest pharma companies)
- Headquarters in Osaka, Japan
- Subsidiary of Mitsubishi Chemical Holdings
- Portfolio company relationship with Bain Capital Life Sciences
- Radicava (edaravone) - FDA-approved ALS treatment
- Focus on CNS, autoimmune, and diabetes
- Global operations with US subsidiary
- Listed on Tokyo Stock Exchange